TMO earnings

THERMO FISHER SCIENTIFIC INC. reported results (Jul 23, 2026). EPS came in at $6.03 against a $5.72 consensus, beat by 5.4%. Revenue was $12.0B versus $11.7B expected, beat by 2.5%.

Thermo Fisher Scientific THERMO FISHER SCIENTIFIC INC. reported Q1 FY2026 results that beat both revenue and EPS estimates, driven by strong operational performance and a favorable foreign exchange tailwind. The company also raised its full-year guidance, signaling continued confidence in its growth trajectory.

THERMO FISHER SCIENTIFIC INC. beat on Q4 revenue and EPS, but the variant read is that the market should not pay for a broad acceleration narrative when the guide embeds only 3% to 4% organic revenue growth and 50 basis points of adjusted operating margin expansion. The actionable semiconductor read-through is narrower: TEM/FIB/SEM demand into TSMC, Samsung, and Intel looks supported, but the company’s own tone deteriorated in confidence as guidance tone rose, which makes Q1 delivery against $11,005.0 million revenue and 40.7% gross margin the confirmation point.

THERMO FISHER SCIENTIFIC INC. cleared the Street on both revenue and EPS, but the variant view is that investors should not pay for the headline beat as a clean demand inflection. The print says the market may be underpricing a margin and capital-deployment reset, while overcrediting organic acceleration that management itself kept at 2% for the year.